Phase I trial of pemetrexed, carboplatin, and sorafenib as first-line treatment in patients with metastatic NSCLC. Background: Erlotinib is a valuable treatment option in some patients (pts.) with non ...
Researchers may have found a new approach to treat cancer by using a plasma treatment to induce apoptosis, without any obvious side effect to normal cells. A plasma-activated medium (PAM) can be ...
Chinese researchers may have found a new approach to treat cancer by using a plasma treatment to induce apoptosis, the death of cancer cells, without any obvious side effect to normal cells. The catch ...
Researchers have shown, for the first time, that a person’s beliefs about nicotine influences brain activity, producing a dose-dependent effect that was only thought to occur with pharmaceutical ...
Racial and Ethnic Differences in Psychosocial Care Use Among Adults With Metastatic Breast Cancer: A Retrospective Analysis Across Six New York City Health Systems Although patients with metastatic ...
WASHINGTON, June 28, 2022 – Chinese researchers may have found a new approach to treat cancer by using a plasma treatment to induce apoptosis, the death of cancer cells, without any obvious side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback